NASDAQ:ALGS

Aligos Therapeutics Stock Forecast

etoro logo Buy ALGS
*Your capital is at risk
$4.23
-0.0900 (-2.08%)
At Close: Jul 31, 2026
AI Analysis AI Analysis of ALGS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ALGS to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Aligos Therapeutics Inc. stock price ended at $4.23 on Friday, after losing 2.08%
(Updated on Jul 31, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 20, 2026 Loss -19.89%

The Aligos Therapeutics Inc. stock price fell by -2.08% on the last day (Friday, 31st Jul 2026) from $4.32 to $4.23. During the last trading day the stock fluctuated 7.47% from a day low at $4.15 to a day high of $4.46. The price has fallen in 5 of the last 10 days and is down by -26.31% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -50 thousand shares and in total, 49 thousand shares were bought and sold for approximately $207.43 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.99 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -14.32% during the next 3 months and, with a 90% probability hold a price between $3.42 and $5.56 at the end of this 3-month period.

ALGS Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, July 24, 2026, and so far it has risen 3.68%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aligos Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.27 and $5.40. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Aligos Therapeutics Inc. stock

Aligos Therapeutics Inc. finds support from accumulated volume at $4.08 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.310 between high and low, or 7.47%. For the last week the stock has had daily average volatility of 7.60%.

Aligos Therapeutics Inc. is oversold on RSI14 (14). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ALGS) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Aligos Therapeutics Inc. to open at $4.28, and during the day (based on 14 day Average True Range), to move between $4.02 and $4.44, which gives a possible trading interval of +/-$0.413 (+/-10.26%) up or down from last closing price. If Aligos Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 10.26% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.08 (3.55%) than the resistance at $4.69 (10.87%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Aligos Therapeutics Inc. will release earnings BMO on Wednesday, August 05, 2026.The consensus among the analysts for the expected earnings (EPS) is -$1.25. We will update the financials statements for Aligos Therapeutics Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 12.79% in the first trading day after earnings release.

Is Aligos Therapeutics Inc. stock A Buy?

Aligos Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.649 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $4.28 ( 1.18%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ALGS Performance

Trading levels for ALGS

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 4.59 8.51%
R2 4.47 5.71%
R1 4.40 3.98%
Price 4.23
S1 4.16 -1.62%
S2 4.09 -3.35%
S3 3.97 -6.15%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.28 24.82%
R2 5.25 24.11%
R1 4.69 10.87%
Price 4.23
S1 4.08 -3.55%
S2 0 -
S3 0 -

FAQ

What is the symbol for Aligos Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Aligos Therapeutics Inc. is ALGS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aligos Therapeutics Inc. Stock?
Aligos Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Aligos Therapeutics Inc. Stock?
Aligos Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aligos Therapeutics Inc. Stock.

What's the current price of Aligos Therapeutics Inc. Stock?
As of the end of day on the Jul 31, 2026, the price of an Aligos Therapeutics Inc. (ALGS) share was $4.23.

What is the 52-week high and low for Aligos Therapeutics Inc. Stock?
The 52-week high for Aligos Therapeutics Inc. Stock is $13.69 and the 52-week low is $3.98.

What is the market capitalization of Aligos Therapeutics Inc. Stock?
As of the Jul 31, 2026, the market capitalization of Aligos Therapeutics Inc. is 26.176M.

When is the next earnings date for Aligos Therapeutics Inc.?
The upcoming earnings date for Aligos Therapeutics Inc. is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT ALIGOS THERAPEUTICS INC.
Aligos Therapeutics
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB); and ALG-000184, a capsid assembly modulator, which is in Phase I clinical trials to treat CHB. The com...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE